STRS Ohio’s Rhythm Pharmaceuticals RYTM Stock Holding History

STRS Ohio’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$666K	Sell	6,000 -22,914	-79%	-$2.07M	﹤0.01%	998
2026 Q1	$2.51M	Buy	28,914 +16,914	+141%	+$1.64M	0.01%	550
2025 Q4	$1.28M	Sell	12,000 -2,800	-19%	-$297K	﹤0.01%	639
2025 Q3	$1.49M	Sell	14,800 -2,600	-15%	-$241K	0.01%	597
2025 Q2	$1.1M	Sell	17,400 -1,100	-6%	-$67.4K	﹤0.01%	881
2025 Q1	$980K	Buy	18,500 +2,100	+13%	+$117K	﹤0.01%	879
2024 Q4	$918K	Buy	16,400 +10,200	+165%	+$563K	﹤0.01%	885
2024 Q3	$325K	Hold	6,200	–	–	﹤0.01%	1423
2024 Q2	$255K	Sell	6,200 -7,400	-54%	-$295K	﹤0.01%	1493
2024 Q1	$589K	Buy	13,600 +10,600	+353%	+$464K	﹤0.01%	1145
2023 Q4	$137K	Buy	+3,000	New	+$94.6K	﹤0.01%	1647
2023 Q2	–	Sell	-14,099	Closed	-$251K	–	2077
2023 Q1	$251K	Buy	+14,099	New	+$354K	﹤0.01%	1545
2020 Q1	–	Sell	-2,400	Closed	-$55K	–	2081
2019 Q4	$55K	Hold	2,400	–	–	﹤0.01%	1882
2019 Q3	$51K	Hold	2,400	–	–	﹤0.01%	1876
2019 Q2	$52K	Hold	2,400	–	–	﹤0.01%	1916
2019 Q1	$65K	Hold	2,400	–	–	﹤0.01%	1848
2018 Q4	$64K	Hold	2,400	–	–	﹤0.01%	1836
2018 Q3	$70K	Hold	2,400	–	–	﹤0.01%	1899
2018 Q2	$75K	Hold	2,400	–	–	﹤0.01%	1911
2018 Q1	$47K	Hold	2,400	–	–	﹤0.01%	1752
2017 Q4	$69K	Buy	+2,400	New	+$63.5K	﹤0.01%	1692

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

STRS Ohio's RYTM Position: Q2 2026 in Review

STRS Ohio reduced its Rhythm Pharmaceuticals (RYTM) stake by 79% in Q2 2026, selling an estimated $2.07M and leaving 6,000 shares worth $666K. The position accounts for ﹤0.01% of the portfolio, ranked #998.

STRS Ohio first reported a position in RYTM in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.51M in Q1 2026. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

STRS Ohio held 6,000 shares of Rhythm Pharmaceuticals worth $666K as of Q2 2026.
STRS Ohio sold 22,914 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $2.07M.
Rhythm Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #998 holding.
STRS Ohio first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 21 quarters since.
STRS Ohio's Rhythm Pharmaceuticals position peaked at $2.51M in Q1 2026.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.